Sandoz at record high after H1 beat

Sandoz AG

07/08/2025 09:33

** Shares in Sandoz SDZ.S rise around 7% to their highest price ever after the Swiss generic drug manufacturer reported better-than-expected H1 results

** Analysts at Vontobel say biosimilar drugs underpin growth, having reached 30% of sales for the first time

** "From a regional perspective, the music plays in Europe - while the US fell short of expectations," they write in a note

** Stock is amongst best performers on pan-European index .STOXX, up 30% YTD and on track for its best day since market debut in October 2023

 (Reporting by Paolo Laudani)

 ((Paolo.laudani@thomsonreuters.com))